<?xml version="1.0" encoding="UTF-8"?>
<p>Drawbacks of HAART include drug resistance, drug toxicity, and the need to know HIV status and CD4 count before offering intervention. As a result, more than 30 HIV vaccines are being tested in human clinical trials worldwide
 <xref ref-type="bibr" rid="b8">8</xref>, including at least one based on a genetically modified killed whole virus
 <xref ref-type="bibr" rid="b37">37</xref>. A prophylactic vaccine would mean that a certain percentage of vaccinated HIVâˆ’ individuals are protected from infection, even if they engage in unprotected sex. As a result, prophylactic vaccines could impact how individuals update their risk perception based on their partner actions, and knowledge of vaccine coverage in the population.
</p>
